|
 Contact us regarding Remicade; attorney consultations are free.
Jul. 2, 07: Accident Raises Safety Concerns About Chinese Tires
Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature. read more »
Jul. 2, 07: Accident Raises Safety Concerns About Chinese Tires
Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature read more »
Jan. 17, 06: Clinical Trials
ANTI-TNF therapy is a new class of drug to treat severe forms of inflammatory arthritis such as rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. There are three drugs - infliximab... read more »
What is Remicade?
Remicade has the generic name of infliximab, and is marketed by Centocor, Inc., a division of Johnson and Johnson. Remicade is part of the class of medications known as tumor necrosis factor inhibitors. Remicade is designed to block a protein in the body known as tumor necrosis factor, or TNF, which is believed to cause inflammation in the body. The blocking of TNF may reduce inflammation in the body. It is prescribed in order to treat various ailments including auto-immune disorders such as rheumatoid arthritis and gastrointestinal problems including Crohn's disease and ulcerative colitis. Remicade has also been used to treat ankylosing spondylitiis and Psoriatic Arthritis. Remicade is in the same class of drugs as Enbrel, marketed by Amgen, and Humira, which, is marketed by Abbott Laboratories. Some reports indicate that the TNF-blocking drugs account for sales of $4.1 billion in the year 2003. Over 634,000 patients worldwide have been treated with Remicade.
Contact us regarding Remicade; attorney consultations are free.
« Back to Remicade page
|
|
| | |
